☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Early-Stage
Guardant Health Presents Results of LUNAR-2 Blood Test for the Treatment of Early-Stage Colorectal Cancer at ACG 2021
October 26, 2021
AstraZeneca's Tagrisso (osimertinib) Receives EU's Approval for the Adjuvant Treatment of Patients with Early-Stage EGFR-Mutated L...
May 28, 2021
Guardant Health Launches Guardant Reveal Liquid Biopsy Test for Early-Stage Colorectal Cancer
February 17, 2021
Load more...
Back to Home
Modal title
×
Modal body text goes here.